top of page

BRINGING

BIOLOGICS MEDICAL INNOVATION TO INTERNATIONAL MARKET

Scroll Down

KGBIO AT A GLANCE

 
Biotechnology company

T

KGbio is a clinical-stage biotech company backed by Kalbe, Genexine, and General Atlantic. Our focus is on licensing biologics and biosimilars in oncology and high-specialty areas, while also providing contract manufacturing services. Join us in bringing biologics medical innovation to international market.

Anchor 1

LATEST NEWS

2024-04-27

Kalbe Launches Anemia Efepoetin Alfa, a Drug for Patients with Chronic Kidney Diseases

2024-03-09

Kalbe Launches Serplulimab, Lung Cancer Therapeutic Drug

2023-10-23

KGbio Received Market Approval for Efesa

businesspeople-meeting-office-hand-shake_edited_edited_edited.jpg

Join Us

We invite you to join us and get success to be part of KGbio

bottom of page